Crossref
Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG)
EMJ Oncology · 2022
DOI: 10.33590/emjoncol/10002372 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMJ Oncology, 2022. Verfasst von Kezhong Cheng und 14 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cheng, K., Kou, H., Zhang, K., Jin, Y., Cui, P., Yang, B., Liu, Y., Wang, C., Li, C., Zhang, Y., Wang, G., Yang, X., Zhou, G., Cai, S., & Yang, F. (2022). Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG). EMJ Oncology. https://doi.org/10.33590/emjoncol/10002372
Vancouver
Cheng K, Kou H, Zhang K, Jin Y, Cui P, Yang B, et al. Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG). EMJ Oncology. 2022. doi:10.33590/emjoncol/10002372
BibTeX
@article{Cheng2022,
author = {Cheng, Kezhong and Kou, Hongyi and Zhang, Kai and Jin, Yichen and Cui, Peng and Yang, Bo and Liu, Yuxiao and Wang, Chengyang and Li, Chengcheng and Zhang, Yuzi and Wang, Guoqiang and Yang, Xingyu and Zhou, Guangyu and Cai, Shangli and Yang, Fan},
title = {Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG)},
journal = {EMJ Oncology},
year = {2022},
doi = {10.33590/emjoncol/10002372}
}
EUVIMED